Dr Peter McCullough: Strong Call for Twice Daily Nasal Spray and Gargle Regimen (2025)

By Editorial Team -
A newer COVID-19 variant may be causing a severe sore throat in some people who contract the infection. The variant, known as NB.1.8.1 (Nimbus), has been nicknamed by some as "razor blade throat" due to the painful symptom.

Dr. McCullough appeared on Real America’s Voice Just the News with Amanda Head and said that the sore throat means the virus has been in the nasal cavity silently reproducing for at least five days before the onset of the sore throat. Because vaccines don’t work, the only way to help reduce the risk of Nimbus is twice daily nasal sprays and gargles. It must be done routinely and not just in reaction to the onset of symptoms where it is too late.

COVID-19 Variant "Nimbus" NB.1.8.1 Causing 'Razor Blade Throat' by Peter A. McCullough, MD, MPH

Strong Call for Twice Daily Nasal Spray and Gargle Regimen

Read on Substack

Comments

Post a Comment

Popular posts from this blog

Dr Peter McCullough: How to Detox Spike Protein from Body

By Editorial Team -
Image
Base Spike Detox According to Dr Peter McCullough (in a X/Twitter post): Base Spike Detox is what I am currently using in my practice for those who have had COVID-19 multiple times, one or more of the COVID-19 vaccines, or both and believe persistent SARS-CoV-2 Spike protein could be causing problems in their body.  I have arrived, based on the emerging scientific literature (1) and my clinical observation, that three OTC products are essential as a triple base combination: Nattokinase 2000 FU (100 mg) twice a day Bromelain 500 mg once a day Nano/Liposomal Curcumin 500 mg twice a day Related: Nattokinase, Bromelain and Curcumin from The Wellness Company Additional products can be added, including NAC, IVM (Ivermectin), HCQ (Hydroxychloroquine), fluvoxamine, low-dose naltrexone, and blood thinners, depending on the clinical evaluation and the syndrome. The therapeut...
Read more

Front Line Doctors Ivermectin Protocol for Prevention and Treatment of COVID-19 (2025)

By Editorial Team -
Image
The Front Line COVID-19 Critical Care (FLCCC*) Alliance was initially formed as a working group during the early COVID-19 pandemic days in response to multiple early reports of COVID patients with an inexplicably high need for prolonged mechanical ventilation and an excessive death rate.  *The FLCCC Alliance is now the  Independent Medical Alliance Based on rapidly emerging clinical trials evidence, the FLCCC team has developed the   I-MASK+ protocol   ( is now divided into I-Prevent and I-Care protocols ) for prophylaxis and at home treatment of early stage COVID-19. Quercetin, zinc and a number of nutrients and drugs are part of this protocol, not only for critical care but also for prophylaxis and mild disease being treated at home. This article, we will dive deeper to provide the scientific background, related references and rationale of the FLCCC protocols. Update:  NB.1.8.1 COVID variant: Symptoms, Spread, and What You Need to Know  (June 2025) FLCCC ...
Read more

Turbo Cancers on the Rise?: 2025 Studies and Updates

By Editorial Team -
Image
A sudden rise in younger people with early onset cancers which are more aggressive with more (and unusual) genetic change has been increasingly noted - colorectal, breast and GI tract cancers seem to lead the way. Genomic Integration and Molecular Dysregulation in Aggressive Stage IV Bladder Cancer Following COVID-19 mRNA Vaccination (October 2025 Study) Bladder cancer is rare in young women, and advanced presentations are exceptionally uncommon. Authors report a de-identified case of a previously healthy 31-year-old female who developed rapidly progressive stage IV bladder cancer within 12 months of completing a three-dose Moderna mRNA vaccination series (May 2021, June 2021, December 2021). ( International Journal of Innovative Research in Medical Science ) This sentinel case report provides the first documented evidence of genomic integration of mRNA vaccine-derived genetic material in a human subject, documenting a temporal association between COVID-19 mRNA vaccination and aggr...
Read more

FLCCC I-Recover Protocol: Post Vaccine Treatment Protocol (2025)

By Editorial Team -
Image
Over the last three years, the COVID-19 pandemic has transformed almost every aspect of our lives before we've had time to stop and question it. Although no official definition exists for post-COVID-vaccine syndrome, a temporal correlation between a patient receiving a COVID-19 vaccine and beginning or worsening of clinical manifestations is sufficient to diagnose as a COVID-19 vaccine-induced injury, when the symptoms are unexplained by other concurrent causes. Dr. Paul Marik and Dr. Pierre Kory are pleased to introduce the I-RECOVER: Post-Vaccine Treatment protocol, designed to help people who have experienced adverse symptoms after a COVID vaccine. Kory and Marik are both part of the FLCCC ( The FLCCC Alliance is now the Independent Medical Alliance ), which was founded in 2020 to share early treatment protocols for COVID-19. Kory is an ICU specialist, triple board certified in internal medicine, critical care and pulmonary medicine. He now runs a priva...
Read more

FLCCC I-CARE COVID Treatment Protocol for Outpatients (2025 Edition)

By Editorial Team -
Image
Early treatment is critical and the most important factor in managing this disease. COVID-19 is a clinical diagnosis; a confirmed antigen or PCR test is not required. Treatment should be initiated immediately after the onset of flu-like symptoms. The multiple therapies and drugs in this protocol have different mechanisms of action and work synergistically during various phases of the disease. About I-CARE Protocol The information in this document is our recommended approach to COVID-19 based on the best (and most recent) literature. It is provided as guidance to healthcare providers worldwide on the early treatment of COVID-19. Patients should always consult with their provider before starting any medical treatment. Updates:  The Stratus Variant (XFG): Symptoms, Global Spread, and Impact in Late 2025 Note: According to Dr Pierre Kory, "...highlighting his objectivity, while Pierre Kory was once the leading advocate for ivermectin to treat COVID, he no longer does as the newer vari...
Read more

Dr Peter McCullough: Povidone Iodine, Oral and Nasal Hygiene (2025)

By Editorial Team -
Image
Dr. Peter McCullough is an internist, cardiologist, epidemiologist, a full professor of medicine at Texas A&M College of Medicine in Dallas, USA. He also has a master's degree in public health and is known for being one of the top five most-published medical researchers in the United States and is the editor of two medical journals. McCullough Protocol 2022 Updates:  Double blind randomized controlled trial of saline solution gargling and nasal rinsing in COVID infection (Nov 2023) What really killed COVID-19 patients: It wasn't a cytokine storm, suggests study  (2023) Everyone is familiar with nasal and oral swab testing for COVID-19. It should be obvious the virus is replicating in the nose, and with Omicron, the speed of replication has become much greater than the pr...
Read more

Fact Check: Unpacking the Spike Protein Debate (2025)

By Editorial Team -
Image
Introduction The rapid development and deployment of COVID-19 vaccines have been monumental in combating the global pandemic, saving countless lives and enabling societies to regain a sense of normalcy. Central to the efficacy of many of these vaccines, particularly mRNA and viral vector-based ones, is the spike protein—a key component of the SARS-CoV-2 virus that facilitates its entry into human cells. By instructing the body to produce a version of this protein, vaccines train the immune system to recognize and neutralize the virus without causing illness. However, as vaccination campaigns expanded, so did public curiosity and concern about the spike protein's role, fueled by a mix of scientific complexity, misinformation, and distrust. This article aims to cut through the noise by providing a fact-based exploration of the spike protein in COVID-19 vaccines. Drawing on peer-reviewed studies, expert insights, and data from health authorities,...
Read more

FLCCC I-CARE Treatment Protocol for Flu and RSV (2025)

By Editorial Team -
Image
A Guide to Diagnosing and Managing Influenza and Respiratory Syncytial Virus (RSV) Infections in Adults In adult patients, COVID-19 (Omicron variant), influenza, and RSV present with similar symptoms and can, therefore, be difficult to distinguish. This guide aims to help diagnose and treat Influenza and Respiratory Syncytial Virus (RSV). Update: Oseltamivir Treatment vs Supportive Care for Seasonal Influenza Requiring Hospitalization (JAMA 2025) For advice on how to protect yourself against infection, see  I-PREVENT: COVID, Flu and RSV Protection Protocol . For treatment of COVID-19, see  I-CARE: Early COVID Treatment Protocol . For treatment of Post Vaccine Complications, see I-RECOVER: Post Vaccine Treatment . Update: Added Minocycline (Jan 2023 update) Note that there are two I-Care Protocols; the I-Care Covid protocol to treat Covid and this protocol, I-Care Flu protocol.  About this Protocol The information in this document is our recommended approach to COVID-19 ...
Read more

Long COVID in 2025: Latest Research, Symptoms, and Treatment Advances

By Editorial Team -
Image
More than four years following the emergence of COVID-19, a subset of individuals experience persistent, multisystem symptoms extending beyond three months post-infection or post-exposure to mRNA-based COVID-19 vaccines.  This condition, historically termed "Long COVID," has recently been redefined by some researchers as "Post-Spike Syndrome" (PSS) or "SPIKEOPATHY," emphasizing the pathogenic role of the SARS-CoV-2 Spike protein derived from both viral infection and mRNA vaccination.  This article summarizes the most recent scientific findings and clinical advances to help patients and healthcare providers better understand and manage this complex condition. Latest Research Insights on Long COVID Immune System Markers and Genetic Risk Factors A recent clinical study led by Cardiff Metropolitan University and Cwm Taf Morgannwg University Health Board identified elevated levels of the immune protein Interleukin-6 (IL-6) in people suffering from Long COVID co...
Read more

COVID Vaccines Increase Cancer Risk, 2025 South Korean Study Concludes

By Editorial Team -
Image
COVID-19 vaccines and boosters — both mRNA and non-mRNA — pose an increased risk of six types of cancer and a   27% higher risk of cancer overall , according to a recent South Korean study of over 8 million people. Four South Korean researchers published the report last week as a letter in Biomarker Research, a Springer Nature journal. According to the study, COVID-19 vaccines and boosters are associated with a higher risk of breast, colorectal, gastric, lung, prostate and thyroid cancer, across all vaccine types and age groups. Mainstream medical commentators were quick to dismiss the findings, with  MedPageToday  describing it as “flawed.” But other medical and scientific experts disagreed. “In plain terms: both major COVID-19 vaccine platforms  appear to be carcinogenic ,” epidemiologist Nicolas Hulscher wrote in a post on Substack. Dr. Angus Dalgleish , a medical oncologist, told  The Defender ...
Read more

Labels

Show more